Monitoring renal function in patients with solid tumors and hematologic malignancies is vital
to the safe administration of therapeutic agents. Renal impairment is frequent in elderly …

Abstract BACKGROUND. The Renal Insufficiency and Cancer Medications (IRMA) study is a
French national observational study. The results from this study of nearly 5000 patients …

Renal insufficiency has been shown to be highly prevalent in patients with cancer. This renal
insufficiency has been reported to be associated with reduced overall survival and …

Background: Chronic renal failure is a common pathology. The high frequency of this
disease in the general US population has been assessed in the NHANES III study. However …

Kidney disease is very common in patients with cancer. Nephrologists are vital members of
the multidisciplinary care team for these patients. Given the high prevalence of comorbidities …

Renal function is an important consideration in the management of patients with advanced
cancer. There is a reciprocal relationship between cancer and the kidney: chronic kidney …

Objective: To assess the prevalence of renal insufficiency (RI) in cancer patients, as well as
describe the profile of anticancer drugs prescribed, need for dose adjustment, and potential …

Background: Renal impairment (RI) has been shown to be one major risk factor in a number
of diseases and is associated with a dismal clinical outcome. However, the influence of …

Anticancer drug nephrotoxicity is an important and increasing adverse drug event that limits
the efficacy of cancer treatment. The kidney is an important elimination pathway for many …

Correct drug dosing of anticancer agents is essential to obtain optimal outcomes.
Overdosing will result in increased toxicity, treatment interruption and possible cessation of …